Literature DB >> 25712184

Genetic variations in NADPH-CYP450 oxidoreductase in a Czech Slavic cohort.

Mária Tomková1, Satya Prakash Panda, Ondřej Šeda, Alice Baxová, Martina Hůlková, Bettie Sue Siler Masters, Pavel Martásek.   

Abstract

AIM: Estimating polymorphic allele frequencies of the NADPH-CYP450 oxidoreductase (POR) gene in a Czech Slavic population.
METHODS: The POR gene was analyzed in 322 individuals from a control cohort by sequencing and high resolution melting analysis.
RESULTS: We identified seven unreported SNP genetic variations, including two SNPs in the 5' flanking region (g.4965C>T and g.4994G>T), one intronic variant (c.1899-20C>T), one synonymous SNP (p.20Ala=) and three nonsynonymous SNPs (p.Thr29Ser, p.Pro384Leu and p.Thr529Met). The p.Pro384Leu variant exhibited reduced enzymatic activities compared with wild-type.
CONCLUSION: New POR variant identification indicates the number of uncommon variants might be specific for each subpopulation being investigated, particularly germane to the singular role that POR plays in providing reducing equivalents to all CYP450s in the endoplasmic reticulum. Original submitted 15 September 2014; Revision submitted 17 November 2014.

Entities:  

Keywords:  CYP; Czech Slavic population; NADPH-cytochrome; P450 oxidoreductase; P450 reductase; POR; allele frequencies; haplotype; pharmacogenetics

Mesh:

Substances:

Year:  2015        PMID: 25712184      PMCID: PMC4662547          DOI: 10.2217/pgs.14.169

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  46 in total

1.  GERBIL: Genotype resolution and block identification using likelihood.

Authors:  Gad Kimmel; Ron Shamir
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-22       Impact factor: 11.205

Review 2.  Function of human cytochrome P450s: characterization of the orphans.

Authors:  F Peter Guengerich; Zhong-Liu Wu; Cheryl J Bartleson
Journal:  Biochem Biophys Res Commun       Date:  2005-08-22       Impact factor: 3.575

3.  Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations.

Authors:  Ningwu Huang; Vishal Agrawal; Kathleen M Giacomini; Walter L Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-29       Impact factor: 11.205

4.  Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis.

Authors:  Ningwu Huang; Amit V Pandey; Vishal Agrawal; William Reardon; Pablo D Lapunzina; David Mowat; Ethylin Wang Jabs; Guy Van Vliet; Joseph Sack; Christa E Flück; Walter L Miller
Journal:  Am J Hum Genet       Date:  2005-03-25       Impact factor: 11.025

5.  Proximal promoter of the cytochrome P450 oxidoreductase gene: identification of microdeletions involving the untranslated exon 1 and critical function of the SP1 binding sites.

Authors:  Shun Soneda; Takashi Yazawa; Maki Fukami; Masanori Adachi; Michiyo Mizota; Kenji Fujieda; Kaoru Miyamoto; Tsutomu Ogata
Journal:  J Clin Endocrinol Metab       Date:  2011-09-07       Impact factor: 5.958

6.  Isolation of a human cytochrome P-450 reductase cDNA clone and localization of the corresponding gene to chromosome 7q11.2.

Authors:  E A Shephard; I R Phillips; I Santisteban; L F West; C N Palmer; A Ashworth; S Povey
Journal:  Ann Hum Genet       Date:  1989-10       Impact factor: 1.670

Review 7.  P450 oxidoreductase deficiency: a new disorder of steroidogenesis with multiple clinical manifestations.

Authors:  Walter L Miller
Journal:  Trends Endocrinol Metab       Date:  2004-09       Impact factor: 12.015

8.  Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley-Bixler syndrome.

Authors:  Masanori Adachi; Katsuhiko Tachibana; Yumi Asakura; Toshiyuki Yamamoto; Keiichi Hanaki; Akira Oka
Journal:  Am J Med Genet A       Date:  2004-08-01       Impact factor: 2.802

9.  Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation.

Authors:  Ana M Gomes; Stefan Winter; Kathrin Klein; Miia Turpeinen; Elke Schaeffeler; Matthias Schwab; Ulrich M Zanger
Journal:  Pharmacogenomics       Date:  2009-04       Impact factor: 2.533

Review 10.  Pharmacogenomics of human P450 oxidoreductase.

Authors:  Amit V Pandey; Patrick Sproll
Journal:  Front Pharmacol       Date:  2014-05-09       Impact factor: 5.810

View more
  2 in total

1.  Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype.

Authors:  Karen M McCammon; Satya P Panda; Chuanwu Xia; Jung-Ja P Kim; Daniela Moutinho; Michel Kranendonk; Richard J Auchus; Eileen M Lafer; Debashis Ghosh; Pavel Martasek; Rekha Kar; Bettie Sue Masters; Linda J Roman
Journal:  J Biol Chem       Date:  2016-08-05       Impact factor: 5.157

2.  POR polymorphisms are associated with 21 hydroxylase deficiency.

Authors:  F Pecori Giraldi; S Einaudi; A Sesta; F Verna; M Messina; C Manieri; E Menegatti; L Ghizzoni
Journal:  J Endocrinol Invest       Date:  2021-03-05       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.